FDA Adverse Event Injury Summary report: N

ASR 300 SPIKED CUP SIZE 54

MDR report key: 2213927 · Received August 12, 2011

Report

Report Number
1818910-2011-15246
Event Type
Injury
Date Received
August 12, 2011
Date of Event
January 19, 2011
Report Date
June 24, 2013
Manufacturer
DEPUY INTERNATIONAL, LTD.
Product Code
KWA
PMA / PMN Number
K040627
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

DEPUY STILL CONSIDERS THIS COMPLAINT CLOSED.

Description of Event or Problem · 1

LITIGATION PAPERS ALLEGE PATIENT WILL NEED TO BE REVISED DUE TO PAIN.

Description of Event or Problem · 1

**UPDATE** - MEDICAL RECORDS RECEIVED (B)(4) 2013. REVISION REPORT OF THE LEFT HIP INDICATES PATIENT HAD ON-GOING PAIN, DISABILITY AND A HIGH COBALT LEVEL. UPON REVISION, THE FOLLOWING WAS FOUND: THIN, YELLOW, CLOUDY FLUID; FAIR AMOUNT OF SCAR TISSUE SURROUNDING THE ARTICULATION; SLIGHT AMOUNT OF METALLOSIS AT THE HEAD AND NECK JUNCTION; EVIDENCE OF FIBROUS INGROWTH ON THE BACK SIDE OF THE CUP. THE INFORMATION RECEIVED DOES NOT CHANGE THE MDR DECISION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ASR 300 SPIKED CUP SIZE 54 ACETABULAR CUP KWA DEPUY INTERNATIONAL, LTD. NA 2814568

Patients

Seq Age Sex Outcome Treatment
1 59 YR Required Intervention